Tamoxifen: a personal retrospective. (Q53446252)

14 May 2018

title

Tamoxifen: a personal retrospective. (English)

1 reference

14 May 2018

1 reference

1

V C Jordan

1 reference

14 May 2018

publication date

1 September 2000

1 reference

14 May 2018

Lancet Oncology Commission

published in

1 reference

14 May 2018

volume

1

1 reference

14 May 2018

issue

1

1 reference

14 May 2018

page(s)

43-49

1 reference

14 May 2018

A new derivative of triphenylethylene: effect on implantation and mode of action in rats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Treatment of menometrorrhagia with an anti-oestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

The pharmacology and clinical uses of tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Synthetic oestrogens in mammary cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Influence of antioestrogens on specific binding of [3H]oestradiol in vitro by nuclei from rat mammary tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Influence of anti-oestrogens on the specific binding in vitro of (3H)oestradiol by cytosol of rat mammary tumours and human breast carcinomata

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

The effect of synthetic anti-oestrogens on the growth and biochemistry of rat mammary tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose Levels

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Tamoxifen (antiestrogen) therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Adjuvant tamoxifen in early-stage breast cancer: effects on intercurrent morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Long-term tamoxifen adjuvant therapy in node-positive breast cancer: a metabolic and pilot clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Tamoxifen and contralateral breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Effects of anti-estrogens on bone in castrated and intact female rats

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Coronary heart disease mortality and adjuvant tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Tamoxifen therapy for breast cancer and endometrial cancer risk.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

The tamoxifen dilemma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

Raloxifene as a multifunctional medicine? Current trials will show whether it is effective in both osteoporosis and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900009-7

7 January 2021

10.1016/S1470-2045(00)00009-7

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018